Baird Financial Group Inc. lifted its position in UnitedHealth Group (NYSE:UNH) by 0.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 227,200 shares of the healthcare conglomerate’s stock after buying an additional 970 shares during the quarter. Baird Financial Group Inc.’s holdings in UnitedHealth Group were worth $50,089,000 as of its most recent SEC filing.
Several other large investors have also recently added to or reduced their stakes in the stock. Jennison Associates LLC boosted its position in UnitedHealth Group by 10.2% during the fourth quarter. Jennison Associates LLC now owns 6,107,513 shares of the healthcare conglomerate’s stock worth $1,346,462,000 after purchasing an additional 565,536 shares during the period. Legal & General Group Plc boosted its position in UnitedHealth Group by 1.3% during the third quarter. Legal & General Group Plc now owns 5,153,894 shares of the healthcare conglomerate’s stock worth $1,009,355,000 after purchasing an additional 68,196 shares during the period. UBS Asset Management Americas Inc. boosted its position in UnitedHealth Group by 11.4% during the fourth quarter. UBS Asset Management Americas Inc. now owns 5,013,564 shares of the healthcare conglomerate’s stock worth $1,105,290,000 after purchasing an additional 512,182 shares during the period. American Century Companies Inc. boosted its position in UnitedHealth Group by 1.4% during the fourth quarter. American Century Companies Inc. now owns 4,943,741 shares of the healthcare conglomerate’s stock worth $1,089,897,000 after purchasing an additional 67,545 shares during the period. Finally, Longview Partners Guernsey LTD boosted its position in UnitedHealth Group by 0.4% during the fourth quarter. Longview Partners Guernsey LTD now owns 4,744,455 shares of the healthcare conglomerate’s stock worth $1,045,963,000 after purchasing an additional 19,610 shares during the period. 86.79% of the stock is owned by institutional investors and hedge funds.
UNH has been the subject of a number of research analyst reports. Credit Suisse Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a research report on Wednesday, December 27th. Evercore ISI reaffirmed an “outperform” rating and set a $255.00 price objective (up from $235.00) on shares of UnitedHealth Group in a research report on Friday, January 12th. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 price objective for the company in a research report on Saturday, January 20th. Goldman Sachs initiated coverage on shares of UnitedHealth Group in a research report on Wednesday, January 3rd. They set a “buy” rating and a $269.00 price objective for the company. Finally, Cantor Fitzgerald lifted their price objective on shares of UnitedHealth Group to $280.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 17th. Two analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the company’s stock. UnitedHealth Group presently has a consensus rating of “Buy” and a consensus price target of $244.06.
UNH stock opened at $223.96 on Friday. The stock has a market capitalization of $221,662.55, a P/E ratio of 22.24, a P/E/G ratio of 1.33 and a beta of 0.77. UnitedHealth Group has a 52 week low of $164.60 and a 52 week high of $250.79. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.73 and a quick ratio of 0.73.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, beating the Zacks’ consensus estimate of $2.50 by $0.09. The business had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. UnitedHealth Group’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.11 earnings per share. sell-side analysts predict that UnitedHealth Group will post 12.51 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, March 20th. Investors of record on Friday, March 9th were paid a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a yield of 1.34%. The ex-dividend date of this dividend was Thursday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 29.79%.
ILLEGAL ACTIVITY WARNING: “Baird Financial Group Inc. Has $50.09 Million Position in UnitedHealth Group (UNH)” was first published by Ticker Report and is owned by of Ticker Report. If you are accessing this news story on another site, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this news story can be viewed at https://www.tickerreport.com/banking-finance/3340012/baird-financial-group-inc-has-50-09-million-position-in-unitedhealth-group-unh.html.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.